The PCSK9 protein distributed in tumor tissue may have a more direct impact on the efficacy of ICIs (7), but no research was conducted discussing the association between efficacy and PCSK9 expression in tumor tissue in advanced NSCLC. Here, PCSK9 is linked to neoplasm.